Mark Cuban Value Plus Drug Firm (MCCPDC) is partnering with most cancers care help firm OncoPower to supply prescribed drugs at a decreased value by way of a platform dubbed Remedy Financial savings Suite.
The suite will probably be built-in inside OncoPower’s Capsule Reminder Instrument, which can alert sufferers of cheaper generic remedy choices out there by way of MCCPDC when sufferers log a brand new remedy into the device.
OncoPower affords oncology sufferers counseling, most cancers neighborhood help teams, academic movies, entry to consultants and data on medical trials.
“We’re excited to work with OncoPower to convey decrease prescription drug costs to shoppers,” Alex Oshmyansky, CEO of Mark Cuban Value Plus Drug Firm, mentioned in an announcement. “Value Plus Medication and OncoPower share a standard purpose of offering shoppers the bottom doable worth for his or her prescription remedy. With Value Plus Medication, shoppers might be assured they’re getting a good worth and the comfort of remedy mailed on to their properties.”
THE LARGER TREND
Earlier this month, MCCPDC introduced a partnership with pharmacy profit supervisor RxPreferred Advantages, marking the corporate’s third PBM collaboration. The corporate beforehand partnered with EmsanaRx and Rightway.
“We’re engaged on including partnerships with PBMs that share our mission of cost-plus pricing, transparency and no rebates. RxPreferred will assist us prolong our mission,” Mark Cuban informed MobiHealthNews in an e-mail in December.
In October, Texas-based MCCPDC introduced its first well being plan partnership with Capital Blue Cross, which permits Capital members and neighborhood organizers to entry lower-cost medicine by way of MCCPDC’s platform.
